脐血免疫与炎症蛋白作为早产儿视网膜病变的预测生物标志物
这项回顾性队列研究纳入110例胎龄≤32.0周的早产单胎婴儿,检测脐血浆中12种免疫/炎症蛋白。结果发现脐血浆IL-6升高与严重ROP显著相关,C5a升高与ROP激光治疗显著相关,但无蛋白与ROP发生相关。联合模型预测严重ROP的AUC为0.840,预测激光治疗的AUC为0.884。
要点
- 脐血浆IL-6升高与严重ROP(>3期)显著相关。
- 脐血浆C5a升高与ROP需激光治疗显著相关。
- 联合IL-6和低出生体重预测严重ROP的AUC为0.840,联合C5a和低出生体重预测激光治疗的AUC为0.884。
核心结论
- 脐血浆IL-6和C5a升高可分别作为预测严重ROP和激光治疗的独立标志物,联合模型预测ROP进展具有良好准确性。
研究设计与样本
- 回顾性队列研究,纳入110例胎龄≤32.0周的早产单胎婴儿,检测出生时脐血浆中12种免疫/炎症蛋白水平。
主要发现
- 110例婴儿中30例(27.3%)诊断为ROP,其中14例(12.7%)为严重ROP,7例(6.4%)接受激光治疗。
- 多因素logistic回归分析显示,脐血浆IL-6升高与严重ROP显著相关,脐血浆C5a升高与ROP激光治疗显著相关。
- 所测脐血浆蛋白均与ROP发生无关联。
- 联合预测模型包含高脐血浆IL-6水平和低出生体重,预测严重ROP的AUC为0.840;包含高脐血浆C5a水平和低出生体重,预测激光治疗的AUC为0.884。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether elevated levels of immune/inflammatory proteins in cord blood, alone or in combination with conventional clinical parameters, can predict the occurrence and progression of retinopathy of prematurity (ROP) in preterm infants. METHODS: This was a retrospective cohort study of 110 premature singleton infants who were born at ≤32.0 weeks. Cord plasma at birth was assayed for interleukin-6, C3a, C5a, matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of metalloproteinase-1, macrophage colony-stimulating factor, endostatin, a proliferation-inducing ligand, insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-2, and calcium-binding protein A8/A9 complex levels. The primary outcome measures were the occurrence of any stage ROP, severe ROP (>stage 3), and vision-threatening type 1 ROP requiring laser treatment. RESULTS: ROP was diagnosed in 30 of 110 infants (27.3%), including 14 (12.7%) with severe ROP. Laser treatment was performed on 7 infants (6.4%). Multiple logistic regression analyses indicated that elevated levels of cord plasma IL-6 were significantly associated with severe ROP, whereas elevated levels of cord plasma C5a were significantly associated with ROP laser treatments. However, none of the proteins measured in the cord plasma were associated with ROP occurrence. Using a stepwise regression procedure, we developed a combined prediction model, which included high cord plasma IL-6 levels and low birth weight for severe ROP (area under the curve [AUC], 0.840), and high cord plasma C5a levels and low birth weight for laser treatment (AUC, 0.884). CONCLUSIONS: Elevated levels of cord plasma IL-6 and C5a could be used as independent markers to predict severe ROP and laser treatment, respectively, with combined models predicting ROP progression with good accuracy.
引用
- Park YJ, Woo SJ, Kim YM, et al. Immune and Inflammatory Proteins in Cord Blood as Predictive Biomarkers of Retinopathy of Prematurity in Preterm Infants. Invest Ophthalmol Vis Sci. 2019. PMID: 31525777. doi:10.1167/iovs.19-27258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。